Shares outstanding · 2019–2025

Starling Oncology shares outstanding

98.9M+30.5% · FY2025

Starling Oncology (STLN) reported 98.9M in shares outstanding for fiscal 2025, +30.5% year on year.

5.8M201923.0M202073.2M202173.3M202274.1M202375.7M202498.9M2025
Starling Oncology — Shares outstanding, 2019–2025
Fiscal yearShares outstandingChangeFiling
FY20252025-12-3198.9M+30.5%Open →
FY20242024-12-3175.7M+2.1%Open →
FY20232023-12-3174.1M+1.2%Open →
FY20222022-12-3173.3M+0.0%Open →
FY20212021-12-3173.2M+218.5%Open →
FY20202020-12-3123.0M+300.0%Open →
FY20192019-12-315.8M—Open →

Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +60.7%

Shares outstanding at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Starling Oncology shares outstanding |url=https://companiesranked.com/en/company/starling-oncology/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Starling Oncology shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/starling-oncology/shares-outstanding

BibTeX

@misc{companiesranked-en-company-starling-oncology-shares-outstanding-2026,
  author       = {{CompaniesRanked}},
  title        = {{Starling Oncology shares outstanding}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/starling-oncology/shares-outstanding}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001799191-26-000017 · August 6, 2026

{{cite web |title=Starling Oncology shares outstanding — 10-Q (0001799191-26-000017) |url=https://www.sec.gov/Archives/edgar/data/1799191/000179919126000017/toi-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Starling Oncology overview